HPV Documentary “Sacrificial Virgins” Wins Australian BEST OF FESTIVAL Award
By Catherine J. Frompovich
What are “sacrificial virgins,” you may be asking?
They are young, pre-teen and/or teenage girls, who are targeted for receiving the human papillomavirus (HPV) vaccines [Gardasil®, Gardasil 9® and Cervarix®] prior to becoming sexually active under the unproven pretext of preventing contracting HPV of which there are over 100 strains, and/or cervical cancer later on in life.
This extraordinary investigative documentary film is produced in three parts:
Part I – Not for the greater good
Part II – Pain and Suffering
Sacrificial Virgins: Part III – A penny for your pain
All three trailers can be seen “en bank” at this YouTube link.
Kudos and congratulations are sent to the entire production staff with special recognition for the foresight and determination of filmmaker Joan Shenton, director Andi Reiss and film editor Ollie Richards.
According to the Press Release dated March 4, 2018, “Sacrificial Virgins” was honored “for investigative journalism at the Watchdog Film Festival, held in Brisbane, Australia.” Furthermore, the PR went on to say,
Festival founder and director James Hyams, himself an investigative journalist, said: “Shenton’s thorough, transnational investigation in search of truth and justice deserves recognition and thus the Watchdog Film Festival has awarded her and her team the Watchdog Spirit Award. Individuals such as Ms Shenton and her team play a very important role in identifying and documenting questionable practices within institutions with the hope of increasing accountability and initiating changes for the betterment of society.”
The announcement of both awards was made at the screening of a special “festival cut” of Sacrificial Virgins. James Hyams added: “Joan Shenton’s documentary Sacrificial Virgins questions the safety of the HPV vaccine by illustrating that many individuals correlate the onset of a disability or the death of their daughter with the vaccine. Shenton questions medical professionals about the methodology of the HPV clinical trials and develops a case that further scientific research needs to be conducted to alleviate growing concern about the risks and benefits of the HPV vaccine.”
The rest of the article can be found here: